Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-11 Riley Jennifer Chief Strategy Officer Sale −2,655 $19.59 $52K 37,041
2026-06-10 Riley Jennifer Chief Strategy Officer Shares withheld for taxes −588 $13.10 $8K 39,696
2026-05-21 Riley Jennifer Chief Strategy Officer Grant or award +34,200 36,855
2026-02-26 Riley Jennifer Chief Strategy Officer Grant or award · Stock Option (Right to Buy) +95,000 95,000
2025-12-10 Riley Jennifer Chief Strategy Officer Shares withheld for taxes −637 $4.10 $3K 2,655
2025-01-01 Riley Jennifer Chief Strategy Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000

Page 1 of 1 · 6 trades